Results 251 to 260 of about 134,090 (261)
Some of the next articles are maybe not open access.

Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung Adenocarcinoma

Advanced Healthcare Materials, 2021
Malignant pleural effusion (MPE) remains a treatment bottleneck in advanced lung cancer, due to its complicated microenvironments and “cold” immunity. Therefore, the search for therapeutic drugs to transform MPE to functionally “hot” one could advance ...
Zhenhuan Song   +5 more
semanticscholar   +1 more source

Autologous tumor cell–derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion

Science Translational Medicine, 2019
This study investigated the application of a therapeutic tumor cell–derived microparticle-based nanodelivery platform in malignant pleural effusion. Insider attack on tumors A major factor that limits the effectiveness of cancer therapy is the ability to
Mengfei Guo   +21 more
semanticscholar   +1 more source

Malignant Pleural Effusion: Still a Long Way to Go.

Reviews on recent clinical trials, 2019
BACKGROUND Malignant pleural effusion, which is a common clinical problem in patients with cancer, may be due to both primary thoracic tumours or to a metastatic spread in the chest and constitutes the first sign of disease in approximately 10% of ...
F. Meriggi
semanticscholar   +1 more source

Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.

Cancer Letters, 2019
Dong Wang   +10 more
semanticscholar   +1 more source

Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis

International Journal of Clinical Oncology, 2017
M. Feng   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy